• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎BA.1突破性感染后抗体免疫的演变

Evolution of antibody immunity following Omicron BA.1 breakthrough infection.

作者信息

Kaku Chengzi I, Starr Tyler N, Zhou Panpan, Dugan Haley L, Khalifé Paul, Song Ge, Champney Elizabeth R, Mielcarz Daniel W, Geoghegan James C, Burton Dennis R, Raiees Andrabi, Bloom Jesse D, Walker Laura M

机构信息

Adimab, LLC, Lebanon, NH 03766, USA.

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

bioRxiv. 2022 Sep 22:2022.09.21.508922. doi: 10.1101/2022.09.21.508922.

DOI:10.1101/2022.09.21.508922
PMID:36172124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9516849/
Abstract

Understanding the evolution of antibody immunity following heterologous SAR-CoV-2 breakthrough infection will inform the development of next-generation vaccines. Here, we tracked SARS-CoV-2 receptor binding domain (RBD)-specific antibody responses up to six months following Omicron BA.1 breakthrough infection in mRNA-vaccinated individuals. Cross-reactive serum neutralizing antibody and memory B cell (MBC) responses declined by two- to four-fold through the study period. Breakthrough infection elicited minimal de novo Omicron-specific B cell responses but drove affinity maturation of pre-existing cross-reactive MBCs toward BA.1. Public clones dominated the neutralizing antibody response at both early and late time points, and their escape mutation profiles predicted newly emergent Omicron sublineages. The results demonstrate that heterologous SARS-CoV-2 variant exposure drives the evolution of B cell memory and suggest that convergent neutralizing antibody responses continue to shape viral evolution.

摘要

了解新冠病毒(SARS-CoV-2)异源突破性感染后抗体免疫的演变情况,将为下一代疫苗的研发提供信息。在此,我们追踪了接种mRNA疫苗的个体在感染奥密克戎BA.1后长达六个月的新冠病毒受体结合域(RBD)特异性抗体反应。在整个研究期间,交叉反应性血清中和抗体和记忆B细胞(MBC)反应下降了两到四倍。突破性感染引发的从头开始的奥密克戎特异性B细胞反应极少,但促使预先存在的交叉反应性MBC向BA.1亲和力成熟。在早期和晚期时间点,公共克隆均主导中和抗体反应,并且它们的逃逸突变谱预测了新出现的奥密克戎亚系。结果表明,异源SARS-CoV-2变体暴露推动了B细胞记忆的演变,并表明趋同的中和抗体反应继续塑造病毒进化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/dd2f2fe1d617/nihpp-2022.09.21.508922v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/166eff0c4427/nihpp-2022.09.21.508922v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/b03b46f09378/nihpp-2022.09.21.508922v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/1be4da8827d8/nihpp-2022.09.21.508922v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/dd2f2fe1d617/nihpp-2022.09.21.508922v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/166eff0c4427/nihpp-2022.09.21.508922v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/b03b46f09378/nihpp-2022.09.21.508922v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/1be4da8827d8/nihpp-2022.09.21.508922v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9785/9516849/dd2f2fe1d617/nihpp-2022.09.21.508922v1-f0004.jpg

相似文献

1
Evolution of antibody immunity following Omicron BA.1 breakthrough infection.奥密克戎BA.1突破性感染后抗体免疫的演变
bioRxiv. 2022 Sep 22:2022.09.21.508922. doi: 10.1101/2022.09.21.508922.
2
Evolution of antibody immunity following Omicron BA.1 breakthrough infection.奥密克戎 BA.1 突破感染后抗体免疫的演变。
Nat Commun. 2023 May 12;14(1):2751. doi: 10.1038/s41467-023-38345-4.
3
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.SARS-CoV-2 奥密克戎 BA.1 突破感染导致接种个体记忆 B 细胞库的晚期重塑。
Immunity. 2023 Sep 12;56(9):2137-2151.e7. doi: 10.1016/j.immuni.2023.07.007. Epub 2023 Aug 4.
4
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.奥密克戎变异株疫苗突破性感染诱导针对 SARS-CoV-2 奥密克戎 BA.1 的交叉中和反应优于单独感染。
Int J Mol Sci. 2022 Jul 12;23(14):7675. doi: 10.3390/ijms23147675.
5
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages.奥密克戎 BA.1 突破性感染灭活 COVID-19 疫苗接种者诱导了针对不同奥密克戎亚谱系的抗体和 T 细胞反应的不同模式。
Emerg Microbes Infect. 2023 Dec;12(1):2202263. doi: 10.1080/22221751.2023.2202263.
6
Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone.与仅感染奥密克戎之前的感染相比,疫苗和突破性感染引发的奥密克戎之前的免疫力能更有效地中和奥密克戎BA.1、BA.2、BA.4和BA.5。
Curr Issues Mol Biol. 2023 Feb 19;45(2):1741-1761. doi: 10.3390/cimb45020112.
7
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.暴露于 BA.4/5 蛋白可导致疫苗接种者体内对奥密克戎 BA.1、BA.2、BA.2.12.1 和 BA.4/5 的中和作用。
Sci Immunol. 2022 Dec 23;7(78):eade9888. doi: 10.1126/sciimmunol.ade9888.
8
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection.奥密克戎突破性感染中针对 SARS-CoV-2 体液免疫的独特特征。
Vaccine. 2023 Nov 13;41(47):7019-7025. doi: 10.1016/j.vaccine.2023.10.035. Epub 2023 Oct 17.
9
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5.奥密克戎 BA.2 突破感染增强了对 BA.2.12.1 和 BA.4/BA.5 的交叉中和作用。
Sci Immunol. 2022 Nov 25;7(77):eade2283. doi: 10.1126/sciimmunol.ade2283. Epub 2022 Nov 18.
10
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.奥密克戎 BA.1 突破感染后预先存在的交叉反应性 B 细胞记忆的召回。
Sci Immunol. 2022 Jul 29;7(73):eabq3511. doi: 10.1126/sciimmunol.abq3511.

本文引用的文献

1
Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.曾接触过新冠病毒既往变种的人群感染BA.5的风险。
N Engl J Med. 2022 Sep 8;387(10):953-954. doi: 10.1056/NEJMc2209479. Epub 2022 Aug 31.
2
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.SARS-CoV-2 奥密克戎亚变种 BA.2.12.1、BA.4 和 BA.5 的抗体逃逸
Nature. 2022 Aug;608(7923):603-608. doi: 10.1038/s41586-022-05053-w. Epub 2022 Jul 5.
3
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
奥密克戎 BA.4 和 BA.5 对疫苗和 BA.1 血清的抗体逃逸。
Cell. 2022 Jul 7;185(14):2422-2433.e13. doi: 10.1016/j.cell.2022.06.005. Epub 2022 Jun 9.
4
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.奥密克戎 BA.1 突破感染促进针对保守表位的跨变体中和及记忆 B 细胞形成。
Sci Immunol. 2022 Sep 16;7(75):eabq2427. doi: 10.1126/sciimmunol.abq2427.
5
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.奥密克戎 BA.1 突破感染后预先存在的交叉反应性 B 细胞记忆的召回。
Sci Immunol. 2022 Jul 29;7(73):eabq3511. doi: 10.1126/sciimmunol.abq3511.
6
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control study.美国大型医疗体系中,针对奥密克戎和德尔塔变异株,BNT162b2 疫苗对住院和急诊科就诊的持久性:一项病例对照研究。
Lancet Respir Med. 2022 Jul;10(7):689-699. doi: 10.1016/S2213-2600(22)00101-1. Epub 2022 Apr 22.
7
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.接种 SARS-CoV-2 mRNA 加强针后,记忆 B 细胞的效力和广度增加。
Nature. 2022 Jul;607(7917):128-134. doi: 10.1038/s41586-022-04778-y. Epub 2022 Apr 21.
8
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants.mRNA-1273 对 SARS-CoV-2 奥密克戎和德尔塔变异株的有效性。
Nat Med. 2022 May;28(5):1063-1071. doi: 10.1038/s41591-022-01753-y. Epub 2022 Feb 21.
9
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.基于信使核糖核酸的新冠病毒疫苗加强针可诱导针对严重急性呼吸综合征冠状病毒2奥密克戎变种的中和免疫力。
Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6.
10
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.人类针对 SARS-CoV-2 感染的 B 细胞反应的漫长进化。
Sci Immunol. 2021 Feb 23;6(56). doi: 10.1126/sciimmunol.abg6916.